Cancer in Transplantation: Prevention and Treatment | Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995 | ISBN 9780792338635

Cancer in Transplantation: Prevention and Treatment

Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995

herausgegeben von J.-L. Touraine und weiteren
Mitwirkende
Herausgegeben vonJ.-L. Touraine
Herausgegeben vonJ. Traeger
Herausgegeben vonH. Bétuel
Herausgegeben vonJ.-M. Dubernard
Herausgegeben vonJ.P. Revillard
Herausgegeben vonC. Dupuy
Buchcover Cancer in Transplantation: Prevention and Treatment  | EAN 9780792338635 | ISBN 0-7923-3863-4 | ISBN 978-0-7923-3863-5
` ... significant amount of new data. The text ... provides interesting data on the epidemiology of malignancies following transplantation, and also on their pathogenesis, management, and potential treatment. In view of the increasing number of patients undergoing transplantation this book is to be welcomed.'
Nephrology Dialysis Transplantation, 13 (1998)

Cancer in Transplantation: Prevention and Treatment

Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995

herausgegeben von J.-L. Touraine und weiteren
Mitwirkende
Herausgegeben vonJ.-L. Touraine
Herausgegeben vonJ. Traeger
Herausgegeben vonH. Bétuel
Herausgegeben vonJ.-M. Dubernard
Herausgegeben vonJ.P. Revillard
Herausgegeben vonC. Dupuy

Malignancies are frequent complications in organ transplantation, mainly as the result of infection with certain viruses and of long-term immunosuppression. The epidemiology confirms that the increased incidence concerns certain cancers, especially HIV-related skin cancers and EBV-related lymphoproliferative malignancies.
This book covers all currently available information on this important topic of the relationships between transplantation and malignancies: preexisting cancers, posttransplant cancers, their etiology and pathophysiology, their prevention and treatment. A significant part of the volume is devoted to prophylaxis, early detection and modern forms of therapy in posttransplant lymphomas. As a conclusion of all these new data, the theory of immunosurveillance deserves to be significantly modified.